Eikon Therapeutics Statistics
Total Valuation
EIKN has a market cap or net worth of $616.40 million. The enterprise value is $337.44 million.
| Market Cap | 616.40M |
| Enterprise Value | 337.44M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EIKN has 54.17 million shares outstanding. The number of shares has increased by 831.80% in one year.
| Current Share Class | 54.17M |
| Shares Outstanding | 54.17M |
| Shares Change (YoY) | +831.80% |
| Shares Change (QoQ) | +60.66% |
| Owned by Insiders (%) | 5.89% |
| Owned by Institutions (%) | 43.11% |
| Float | 29.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.32 |
| P/TBV Ratio | 1.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.89, with a Debt / Equity ratio of 0.54.
| Current Ratio | 9.89 |
| Quick Ratio | 9.61 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -404.36 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -46.73% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$838,961 |
| Employee Count | 384 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 10.57 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 54.27 |
| Average Volume (20 Days) | 502,038 |
Short Selling Information
The latest short interest is 4.18 million, so 7.72% of the outstanding shares have been sold short.
| Short Interest | 4.18M |
| Short Previous Month | 4.88M |
| Short % of Shares Out | 7.72% |
| Short % of Float | 13.99% |
| Short Ratio (days to cover) | 12.79 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -338.45M |
| Pretax Income | -322.16M |
| Net Income | -322.16M |
| EBITDA | -317.23M |
| EBIT | -338.45M |
| Earnings Per Share (EPS) | -$13.72 |
Balance Sheet
The company has $531.18 million in cash and $252.22 million in debt, with a net cash position of $278.96 million or $5.15 per share.
| Cash & Cash Equivalents | 531.18M |
| Total Debt | 252.22M |
| Net Cash | 278.96M |
| Net Cash Per Share | $5.15 |
| Equity (Book Value) | 466.50M |
| Book Value Per Share | 8.62 |
| Working Capital | 491.68M |
Cash Flow
In the last 12 months, operating cash flow was -$256.02 million and capital expenditures -$3.18 million, giving a free cash flow of -$259.20 million.
| Operating Cash Flow | -256.02M |
| Capital Expenditures | -3.18M |
| Depreciation & Amortization | 21.22M |
| Net Borrowing | n/a |
| Free Cash Flow | -259.20M |
| FCF Per Share | -$4.79 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EIKN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -831.80% |
| Shareholder Yield | -831.80% |
| Earnings Yield | -52.27% |
| FCF Yield | -42.05% |
Analyst Forecast
The average price target for EIKN is $24.60, which is 116.17% higher than the current price. The consensus rating is "Buy".
| Price Target | $24.60 |
| Price Target Difference | 116.17% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |